Apollo Hospitals Enterprise Limited
NSE: APOLLOHOSP BSE: APOLLOHOSP
Prev Close
7073.5
Open Price
7150
Volume
244,562
Today Low / High
7058 / 7189
52 WK Low / High
5693.2 / 7545.35
Range
6,785 - 7,500
Prev Close
7073
Open Price
7100.3
Volume
2,473
Today Low / High
7065 / 7189.55
52 WK Low / High
5690.8 / 7545.1
Range
6,784 - 7,498
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 7142.5 (target range: 6,785 - 7,500), reflecting a change of 69 (0.97547%). On the BSE, it is listed at 7141 (target range: 6,784 - 7,498), showing a change of 68 (0.9614%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Apollo Hospitals Enterprise Limited Graph
Apollo Hospitals Enterprise Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Apollo Hospitals Enterprise Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 7,142.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 7,141.00 | 7,212.41 | 6,491.17 - 7,933.65 |
| 7,283.82 | 5,827.06 - 8,740.58 | ||
| 7,355.23 | 5,148.66 - 9,561.80 | ||
| Bearish Scenario | 7,141.00 | 7,069.59 | 6,362.63 - 7,776.55 |
| 6,998.18 | 5,598.54 - 8,397.82 | ||
| 6,926.77 | 4,848.74 - 9,004.80 |
Overview of Apollo Hospitals Enterprise Limited
ISIN
INE437A01024
Industry
Medical - Care Facilities
Vol.Avg
404,713
Market Cap
1,026,981,862,625
Last Dividend
19
Official Website
IPO Date
2002-07-01
DCF Diff
-122.94
DCF
7,308
Financial Ratios Every Investor Needs
Stock Dividend of APOLLOHOSP
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-02-14 | February 14, 25 | 9 | 9 | 2025-02-15 | 2025-02-28 | |
| 2024-08-16 | August 16, 24 | 10 | 10 | 2024-08-17 | 2024-09-09 | |
| 2024-02-20 | February 20, 24 | 6 | 6 | 2024-02-20 | 2024-03-06 | |
| 2023-08-18 | August 18, 23 | 9 | 9 | 2023-08-19 | 2023-09-27 | |
| 2023-02-24 | February 24, 23 | 6 | 6 | 2023-02-24 | 2023-03-10 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 19,059.20 Cr | 15,570.70 Cr | 3,488.50 Cr | 0.1830 | 23.40 Cr | 1,894.70 Cr | 1,707.30 Cr | 898.60 Cr | 62.50 | 2,402.00 Cr | 0.0471 |
| 2023-03-31 | 16,612.45 Cr | 8,574.23 Cr | 8,038.22 Cr | 0.4839 | 21.10 Cr | 1,492.90 Cr | 1,449.20 Cr | 819.10 Cr | 56.97 | 2,139.30 Cr | 0.0493 |
| 2022-03-31 | 14,536.20 Cr | 7,573.50 Cr | 6,962.70 Cr | 0.4790 | 11.00 Cr | 1,219.10 Cr | 1,588.40 Cr | 1,055.60 Cr | 73.42 | 2,556.80 Cr | 0.0726 |
| 2021-03-31 | 10,468.00 Cr | 5,684.20 Cr | 4,783.80 Cr | 0.4570 | 0.00 Cr | 718.30 Cr | 567.20 Cr | 150.40 Cr | 10.74 | 1,242.40 Cr | 0.0144 |
| 2020-03-31 | 11,171.50 Cr | 5,498.90 Cr | 5,672.60 Cr | 0.5078 | 0.00 Cr | 804.90 Cr | 971.30 Cr | 454.90 Cr | 32.69 | 1,811.90 Cr | 0.0407 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 505.50 Cr | 16,753.10 Cr | 9,432.60 Cr | 6,935.4000 Cr | 5,332.60 Cr | 4,827.10 Cr | 459.80 Cr | 9,385.20 Cr | 135.60 Cr | 0.00 Cr | 356.70 Cr | 4,664.5000 Cr |
| 2023-03-31 | 433.42 Cr | 14,427.73 Cr | 7,896.45 Cr | 6,197.1400 Cr | 4,332.36 Cr | 3,898.94 Cr | 390.19 Cr | 8,033.73 Cr | 275.03 Cr | 673.62 Cr | 414.50 Cr | 3,324.8000 Cr |
| 2022-03-31 | 583.00 Cr | 13,192.40 Cr | 7,314.70 Cr | 5,623.3000 Cr | 4,068.10 Cr | 3,485.10 Cr | 431.90 Cr | 7,279.20 Cr | 408.00 Cr | 622.00 Cr | 390.10 Cr | 2,383.3000 Cr |
| 2021-03-31 | 425.20 Cr | 11,416.70 Cr | 6,614.30 Cr | 4,602.5000 Cr | 4,159.70 Cr | 3,734.50 Cr | 249.50 Cr | 6,545.80 Cr | 372.10 Cr | 612.40 Cr | 344.90 Cr | 2,037.8000 Cr |
| 2020-03-31 | 380.70 Cr | 11,338.40 Cr | 7,868.60 Cr | 3,339.1000 Cr | 5,620.70 Cr | 5,240.00 Cr | 737.80 Cr | 7,260.90 Cr | 338.80 Cr | 517.40 Cr | 359.20 Cr | 2,337.3000 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,920.2000 Cr | -1,537.2000 Cr | -311.1000 Cr | 783.4000 Cr | 72.1000 Cr | 505.5000 Cr | -1,136.8000 Cr | 898.6000 Cr | 224.6000 Cr | -215.7000 Cr | -69.2000 Cr |
| 2023-03-31 | 1,377.0500 Cr | -870.6100 Cr | -633.3300 Cr | 248.5300 Cr | -113.1300 Cr | 433.4200 Cr | -1,128.5200 Cr | 844.5700 Cr | 68.8000 Cr | -255.2000 Cr | 41.9300 Cr |
| 2022-03-31 | 1,628.0000 Cr | -778.2000 Cr | -792.6000 Cr | 970.8000 Cr | 157.8000 Cr | 583.0000 Cr | -657.2000 Cr | 1,108.4000 Cr | -493.1000 Cr | -43.3000 Cr | -175.8000 Cr |
| 2021-03-31 | 1,273.4000 Cr | -872.3000 Cr | -340.1000 Cr | 977.9000 Cr | 44.5000 Cr | 425.2000 Cr | -295.5000 Cr | 136.8000 Cr | -898.5000 Cr | -38.3000 Cr | -94.6000 Cr |
| 2020-03-31 | 1,292.8000 Cr | -288.8000 Cr | -909.5000 Cr | 779.8000 Cr | 94.5000 Cr | 380.7000 Cr | -513.0000 Cr | 431.7000 Cr | -186.0000 Cr | -155.1000 Cr | -153.1000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 5,526.90 Cr | 2,900.70 Cr | 2,626.20 Cr | 0.4752 | 576.90 Cr | 372.30 Cr | 25.89 | 830.60 Cr | 0.0674 |
| 2024-09-30 | 5,589.30 Cr | 2,857.70 Cr | 2,731.60 Cr | 0.4887 | 631.00 Cr | 378.80 Cr | 26.34 | 859.40 Cr | 0.0678 |
| 2024-06-30 | 5,085.60 Cr | 3,458.50 Cr | 1,627.10 Cr | 0.3199 | 497.70 Cr | 305.20 Cr | 21.23 | 712.30 Cr | 0.0600 |
| 2024-03-31 | 4,943.90 Cr | 3,380.30 Cr | 1,563.60 Cr | 0.3163 | 450.80 Cr | 253.80 Cr | 17.65 | 668.60 Cr | 0.0513 |
| 2023-12-31 | 4,850.60 Cr | 2,533.10 Cr | 2,317.50 Cr | 0.4778 | 475.90 Cr | 245.30 Cr | 17.06 | 641.50 Cr | 0.0506 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1,435.30 Cr | 2,008.70 Cr | 3,444.00 Cr | 0.00 Cr | 448.20 Cr | 7,338.20 Cr | 10,084.40 Cr | 19,547.90 Cr | 11,633.30 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 1,189.50 Cr | 0.00 Cr | 0.00 Cr | 1,189.50 Cr | 0.00 Cr | 0.00 Cr | -7,320.50 Cr |
| 2024-03-31 | 933.80 Cr | 684.00 Cr | 1,617.80 Cr | 2,818.00 Cr | 459.80 Cr | 5,279.70 Cr | 9,385.20 Cr | 16,753.10 Cr | 9,432.60 Cr |
| 2023-12-31 | -1,431.40 Cr | 2,862.80 Cr | 1,431.40 Cr | 0.00 Cr | 0.00 Cr | 1,431.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 472.40 Cr | 1,089.40 Cr | 1,561.80 Cr | 2,549.90 Cr | 423.40 Cr | 4,887.80 Cr | 8,498.70 Cr | 15,560.90 Cr | 8,683.30 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 305.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 253.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 245.30 Cr | 334.00 Cr | 0.00 Cr | 0.00 Cr | 334.00 Cr | 1,203.00 Cr | 869.00 Cr | 0.00 Cr | 334.00 Cr |
| 2023-09-30 | 232.90 Cr | 326.80 Cr | 0.00 Cr | 0.00 Cr | 326.80 Cr | 869.00 Cr | 542.20 Cr | 0.00 Cr | 326.80 Cr |
| 2023-06-30 | 166.60 Cr | 29.20 Cr | 0.00 Cr | 0.00 Cr | -675.50 Cr | 29.20 Cr | 704.70 Cr | 0.00 Cr | 29.20 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2010-09-02 | September 02, 10 | 2:1 |
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,073.00 | ₹1,043,108,366,000.00 | ₹2,069,900.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,142.50 | ₹1,026,981,862,625.00 | ₹244,562.00 |
| Fortis Healthcare Limited | FORTIS | ₹656.30 | ₹495,479,001,030.00 | ₹1,053,239.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,823.60 | ₹372,672,354,880.00 | ₹581,951.00 |
| Global Health Limited | MEDANTA | ₹1,253.40 | ₹336,647,409,558.00 | ₹184,457.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹660.75 | ₹264,391,811,213.00 | ₹494,824.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹503.10 | ₹251,305,020,486.00 | ₹401,567.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,489.80 | ₹151,291,683,925.00 | ₹172,635.00 |
| HealthCare Global Enterprises Limited | HCG | ₹595.65 | ₹83,042,765,141.00 | ₹327,635.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹281.10 | ₹39,044,688,804.00 | ₹71,957.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹425.70 | ₹39,025,196,100.00 | ₹189,533.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: male
Year Born: 1969
Gender: female
Year Born: 1982
Gender: male
Year Born: 1952
Gender: male
Year Born: 1975
Gender: female
Year Born: 1959
Gender: Not Specified
Year Born: 1962
Gender: Not Specified
Year Born: 1957
Gender: male
Year Born: 1955
Gender: Not Specified
Year Born: 1932
Gender: male
Year Born: 1969
FAQs about Apollo Hospitals Enterprise Limited
The CEO is Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS.
The current price is ₹7,142.50.
The range is ₹5693.2-7545.35.
The market capitalization is ₹102,698.19 crores.
The dividend yield is 0.27%.
The P/E ratio is 78.40.
The company operates in the Healthcare sector.
Overview of Apollo Hospitals Enterprise Limited (ISIN: INE437A01024) is a leading Medical - Care Facilities in India. With a market capitalization of ₹102,698.19 crores and an average daily volume of 404,713 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹19.